OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
8.64
-0.10 (-1.14%)
At close: Mar 28, 2025, 4:00 PM
8.66
+0.02 (0.21%)
After-hours: Mar 28, 2025, 7:56 PM EDT

OptimizeRx Statistics

Total Valuation

OptimizeRx has a market cap or net worth of $159.76 million. The enterprise value is $179.57 million.

Market Cap 159.76M
Enterprise Value 179.57M

Important Dates

The last earnings date was Wednesday, March 12, 2025, before market open.

Earnings Date Mar 12, 2025
Ex-Dividend Date n/a

Share Statistics

OptimizeRx has 18.49 million shares outstanding. The number of shares has increased by 6.82% in one year.

Current Share Class 18.49M
Shares Outstanding 18.49M
Shares Change (YoY) +6.82%
Shares Change (QoQ) +0.52%
Owned by Insiders (%) 14.63%
Owned by Institutions (%) 59.03%
Float 14.28M

Valuation Ratios

PE Ratio n/a
Forward PE 21.83
PS Ratio 1.72
Forward PS 1.58
PB Ratio 1.36
P/TBV Ratio 260.61
P/FCF Ratio 33.44
P/OCF Ratio 32.68
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.95
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 37.59

Financial Position

The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.28.

Current Ratio 2.89
Quick Ratio 2.77
Debt / Equity 0.28
Debt / EBITDA n/a
Debt / FCF 6.95
Interest Coverage -1.01

Financial Efficiency

Return on equity (ROE) is -16.51% and return on invested capital (ROIC) is -2.48%.

Return on Equity (ROE) -16.51%
Return on Assets (ROA) -2.19%
Return on Invested Capital (ROIC) -2.48%
Return on Capital Employed (ROCE) -4.08%
Revenue Per Employee $714,163
Profits Per Employee -$155,891
Employee Count 129
Asset Turnover 0.52
Inventory Turnover n/a

Taxes

In the past 12 months, OptimizeRx has paid $725,000 in taxes.

Income Tax 725,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -28.89% in the last 52 weeks. The beta is 1.31, so OptimizeRx's price volatility has been higher than the market average.

Beta (5Y) 1.31
52-Week Price Change -28.89%
50-Day Moving Average 6.21
200-Day Moving Average 7.12
Relative Strength Index (RSI) 64.13
Average Volume (20 Days) 1,236,232

Short Selling Information

The latest short interest is 1.72 million, so 9.29% of the outstanding shares have been sold short.

Short Interest 1.72M
Short Previous Month 1.41M
Short % of Shares Out 9.29%
Short % of Float 12.03%
Short Ratio (days to cover) 1.56

Income Statement

In the last 12 months, OptimizeRx had revenue of $92.13 million and -$20.11 million in losses. Loss per share was -$1.10.

Revenue 92.13M
Gross Profit 59.38M
Operating Income -6.22M
Pretax Income -25.32M
Net Income -20.11M
EBITDA -1.89M
EBIT -6.22M
Loss Per Share -$1.10
Full Income Statement

Balance Sheet

The company has $13.38 million in cash and $33.19 million in debt, giving a net cash position of -$19.81 million or -$1.07 per share.

Cash & Cash Equivalents 13.38M
Total Debt 33.19M
Net Cash -19.81M
Net Cash Per Share -$1.07
Equity (Book Value) 117.00M
Book Value Per Share 6.34
Working Capital 35.32M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $4.89 million and capital expenditures -$112,000, giving a free cash flow of $4.78 million.

Operating Cash Flow 4.89M
Capital Expenditures -112,000
Free Cash Flow 4.78M
FCF Per Share $0.26
Full Cash Flow Statement

Margins

Gross margin is 64.45%, with operating and profit margins of -6.75% and -21.83%.

Gross Margin 64.45%
Operating Margin -6.75%
Pretax Margin -21.04%
Profit Margin -21.83%
EBITDA Margin -2.05%
EBIT Margin -6.75%
FCF Margin 5.19%

Dividends & Yields

OptimizeRx does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.82%
Shareholder Yield n/a
Earnings Yield -12.59%
FCF Yield 2.99%

Analyst Forecast

The average price target for OptimizeRx is $9.06, which is 4.86% higher than the current price. The consensus rating is "Buy".

Price Target $9.06
Price Target Difference 4.86%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on May 14, 2018. It was a reverse split with a ratio of 0.33333:1.

Last Split Date May 14, 2018
Split Type Reverse
Split Ratio 0.33333:1

Scores

OptimizeRx has an Altman Z-Score of 1.98 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.98
Piotroski F-Score 5